Lack of genetic evidence for NLRP3 inflammasome involvement in Parkinson’s disease pathogenesis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Lack of genetic evidence for NLRP3 inflammasome involvement in Parkinson’s disease pathogenesis ; volume:10 ; number:1 ; day:5 ; month:8 ; year:2024 ; pages:1-5 ; date:12.2024
npj Parkinson's Disease ; 10, Heft 1 (5.8.2024), 1-5, 12.2024
- Urheber
-
Senkevich, Konstantin
Liu, Lang
Alvarado, Chelsea X.
Leonard, Hampton L.
Nalls, Mike A.
Gan-Or, Ziv
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41531-024-00744-9
- URN
-
urn:nbn:de:101:1-2410252124295.663197951302
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Senkevich, Konstantin
- Liu, Lang
- Alvarado, Chelsea X.
- Leonard, Hampton L.
- Nalls, Mike A.
- Gan-Or, Ziv
- SpringerLink (Online service)
Ähnliche Objekte (12)
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson’s disease: mechanisms and therapeutic implications
Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson’s disease
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson’s Disease Mice and LPS-Induced BV2 Cells
The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson’s disease via the microglial NLRP3 inflammasome
Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson’s disease
Cerebellar involvement in Parkinson’s disease resting tremor
Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients
MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson’s disease
NLRP3 inflammasome: a key player in the pathogenesis of life-style disorders
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson’s disease: mechanisms and therapeutic implications
Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson’s disease
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson’s Disease Mice and LPS-Induced BV2 Cells
The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson’s disease via the microglial NLRP3 inflammasome
Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson’s disease
Cerebellar involvement in Parkinson’s disease resting tremor
Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients
MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson’s disease
NLRP3 inflammasome: a key player in the pathogenesis of life-style disorders
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson’s disease: mechanisms and therapeutic implications
Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson’s disease
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson’s Disease Mice and LPS-Induced BV2 Cells
The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson’s disease via the microglial NLRP3 inflammasome
Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson’s disease
Cerebellar involvement in Parkinson’s disease resting tremor
Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients
MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson’s disease